Haematology News and Research

RSS

OGT makes several advances in hybridization-based targeted sequencing

Oxford Gene Technology, The Molecular Genetics Company, has made several advances in hybridisation-based target enrichment protocols that now enable researchers to prepare samples for sequencing in just one day.

26 May 2017

Study shows how different genetic mutations cause acute myeloid leukemia

A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukemia.

23 May 2017

New technology could hold key to predicting outcome of blood cancer patients

Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.

11 May 2017

Scientists announce ‘outstanding’ results of new blood cancer study

Scientists have described new results of a blood cancer study as 'outstanding' in tackling previously untreatable forms of chronic lymphocytic leukemia.

27 Apr 2017

Addressing unmet needs in prostate cancer

Prostate cancer is the second most diagnosed cancer globally with over a million men diagnosed worldwide. We are fortunate in that better diagnostic techniques and better awareness means that men are often being diagnosed earlier, which gives them a better chance of being cured.

19 Apr 2017

FAU researchers discover key factor for early metastases in pancreatic cancer

Pancreatic cancer is one of the most aggressive tumour types because it starts forming metastases early. The cancer itself, however, is usually only discovered late. This leads to a high patient mortality rate. Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg have now discovered why pancreatic cancer and other malignant types of tumours can disseminate so rapidly.

18 Apr 2017

Global inequalities in survival for childhood leukemia still persist in some countries, study finds

Although global inequalities in survival from childhood leukemia have narrowed, they still persist with five-year survival in some countries nearly twice as high as in others for children diagnosed during 2005-2009, according to a study published in The Lancet Haematology.

13 Apr 2017

Research uncovers vast inequalities in cancer care for older patients with leukaemia

New research conducted by Leukaemia CARE into the lives of older people living with blood cancers has uncovered vast inequalities in cancer care for the elderly compared with younger patients.

28 Mar 2017

Statins could reduce threat of venous thromboembolism, research shows

Statins could hold the key to eradicating one of the most preventable causes of hospital deaths after researchers uncovered a new role for the cholesterol-lowering pill.

19 Jan 2017

Prevalence of atrial fibrillation in haemodialysis patients higher than previously thought

Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes.

16 Jan 2017

Combined endocrine and targeted therapy could be effective in treating Asian breast cancer patients

Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial presented at the ESMO Asia 2016 Congress in Singapore.

17 Dec 2016

One fifth of breast cancer patients do not complete their prescribed endocrine therapy

Around 20% of breast cancer patients do not complete prescribed endocrine therapy, researchers report at the ESMO Asia 2016 Congress in Singapore.1 The study in over 5,500 women found that younger patients and those who had taken hormone replacement therapy (HRT) were less likely to adhere to their medicine.

14 Dec 2016

Study explores causes of diagnostic delays and impact on treatment in cancer patients

Patients wait an average of four months before seeking a cancer diagnosis, researchers report at the ESMO ASIA 2016 Congress in Singapore.

7 Dec 2016

Project to help those living with HIV launched by Beckman Coulter

Beckman Coulter Life Sciences is launching an international HIV/AIDS award at the 2016 conference for the African Society for Laboratory Medicine (ASLM) being held in Cape Town, South Africa (December 3 to 8).

From Beckman Coulter Diagnostics 5 Dec 2016

biosurfit announces CE Marking for new HbA1c test

Today, biosurfit SA, the in vitro point-of-care (PoC) diagnostics company, announces CE Marking (Conformité Européenne) for its HbA1c (Haemoglobin A1c) test, the third in a series of tests available on its spinit point-of-care instrument.

1 Dec 2016

World Cancer Congress: DITTA urges development of integrated care approaches in medical technology

In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.

4 Nov 2016

OGT announces expansion of Cytocell Aquarius Haematology FISH probe range

Oxford Gene Technology, The Molecular Genetics Company, has today announced a significant expansion of its existing catalogue of Cytocell Aquarius Haematology probes for fluorescence in situ hybridisation (FISH) — underlining the company's position as the one-stop-shop for high-quality FISH probes.

13 Oct 2016

Beckman Coulter’s new DxH 500 haematology system installed at University of Chester’s Institute of Medicine

Beckman Coulter has installed the first DxH 500 haematology analyser in the UK at the University of Chester’s Institute of Medicine on the Countess of Chester Health Park.

From Beckman Coulter Diagnostics 20 Sep 2016

Leading experts in iron deficiency to participate in 3rd European Iron Academy meeting

The 3rd European Iron Academy (EIA) will take place on the 12th and 13th September 2016 in Berlin, Germany, and will bring together over 450 clinicians with an interest in iron deficiency.

From CSL Ltd 16 Sep 2016

NICE MIB offers SD-IORT using Xoft Axxent electronic brachytherapy system for early stage breast cancer patients

NICE (National Institute for Health and Care Excellence) has announced a new Medtech Innovation Briefing (MIB) stating that NHS doctors and commissioners may consider Single Dose Intraoperative Radiotherapy (SD-IORT) using the Xoft Axxent electronic brachytherapy system with ORL managed service as a treatment option for early stage breast cancer patients.

6 Sep 2016